Is VRTX a good investment in 2026?

Vertex Pharmaceuticals trades at a P/E ratio of 32.6, with high volatility (44.5% annualized). Recent momentum is positive.

What is the risk level of VRTX?

Based on 30-day volatility of 44.5%, VRTX has HIGH risk. Beta of 0.32 indicates lower sensitivity to market movements than average.

Vertex Pharmaceuticals (VRTX) Stock Analysis & Price Target

Q: Does VRTX pay dividends?

Vertex Pharmaceuticals currently does not pay a regular dividend.

Key Metrics

MARKET CAP

$126.79B

P/E RATIO

32.6

BETA

0.32

Less volatile

DIV YIELD

N/A

52W HIGH

$519.68

52W LOW

$362.50

VOLATILITY

44.5%

30d annualized

Price Performance

30-DAY PRICE CHART

$470.87 → $499.17+6.01%

30 days agoToday

1-YEAR PERFORMANCE

$504.77 → $499.17-1.1%

VRTX | 52-week chartLast updated: 3/11/2026

Healthcare Sector Context

Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.

METRIC	VRTX	SECTOR AVG	VS SECTOR
P/E Ratio	32.6x	22.0x	↑ 48%
Beta	0.32	0.85	Less volatile
30d Volatility	44.5%	22%	Higher risk

TOP HEALTHCARE PEERS

UNH

JNJ PFPFE

Competitors Analysis

Compare VRTX's key metrics against its main healthcare sector competitors.

COMPANY	PRICE	MARKET CAP	SECTOR
VRVRTX(You are here)	$499.17	$126.79B	Healthcare	—
UNH	$282.34	$256.27B	Healthcare	VIEW →
JNJ	$243.71	$587.32B	Healthcare	VIEW →
PFPFE	$27.16	$154.44B	Healthcare	VIEW →

Click on a competitor to view their full analysis

Technical Analysis

Vertex Pharmaceuticals is currently trading at $499.17, which is 3.9% below its 52-week high. With a beta of 0.32, the stock shows lower sensitivity to market movements.

RSI (14)NEUTRAL

30-DAY TRENDBULLISH

VOLUME3.4M(Above avg)

Frequently Asked Questions

Is VRTX a good buy right now?

Vertex Pharmaceuticals trades at 32.6x earnings. This is above market average, reflecting growth expectations. Current risk level is High based on 44.5% volatility.

Does VRTX pay dividends?

Vertex Pharmaceuticals does not currently pay a regular dividend. The company may be reinvesting profits for growth.

How volatile is VRTX?

With 30-day annualized volatility of 44.5% and beta of 0.32,VRTX is classified as High risk. The stock tends to be more stable than the market average.